MedPath

Oxybutynin Chloride

Oxybutynin Chloride Tablets

Approved
Approval ID

97f3f988-6bf1-453c-9be2-6671119a6f0b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 18, 2019

Manufacturers
FDA

Marlex Pharmaceuticals Inc

DUNS: 782540215

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxybutynin Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10135-640
Application NumberANDA209823
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxybutynin Chloride
Product Specifications
Route of AdministrationORAL
Effective DateOctober 30, 2019
FDA Product Classification

INGREDIENTS (6)

OXYBUTYNIN CHLORIDEActive
Quantity: 5 mg in 1 1
Code: L9F3D9RENQ
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxybutynin Chloride - FDA Drug Approval Details